How to Get Armour Thyroid in Oklahoma

At a glance
- Drug / Armour Thyroid (desiccated thyroid extract, porcine-derived)
- Manufacturer / Allergan (AbbVie portfolio)
- Indication / Hypothyroidism (primary, secondary, and subclinical where clinically appropriate)
- Prescription status / Prescription only in Oklahoma
- Telehealth prescribing / Permitted under Oklahoma telehealth law
- Compounding access / 503A pharmacies in Oklahoma may compound natural desiccated thyroid
- Typical starting dose / 30 mg (0.5 grain) once daily on empty stomach
- Oklahoma Medicaid coverage / Not covered; private insurance coverage varies
- Labs required before first Rx / TSH, Free T4, Free T3 (plus TPO antibodies if autoimmune suspected)
- Time from consult to delivery / 3 to 7 business days in most cases
What Is Armour Thyroid and Why Do Some Patients Prefer It
Armour Thyroid is a prescription porcine-derived desiccated thyroid extract (DTE) that contains both thyroxine (T4) and triiodothyronine (T3) in an approximately 4:1 ratio by weight. Synthetic levothyroxine supplies only T4, which peripheral tissue must convert to the active T3 form. Some patients on levothyroxine continue to report fatigue, cognitive fog, and weight difficulty despite a normalized TSH, and a subset of those patients report improvement on combination therapy or DTE.
The JCEM 2013 trial by Hoang et al. (N=70) found that 49% of hypothyroid patients preferred DTE over levothyroxine after a blinded crossover period, and patients on DTE lost a mean of 0.9 kg more body weight 1. That preference signal, while from a relatively small trial, has shaped prescriber attitudes toward offering DTE as a documented alternative rather than a last resort.
The American Thyroid Association's 2014 guidelines acknowledge that "some patients on levothyroxine do not feel well and some may benefit from the addition of liothyronine" 2. Armour Thyroid carries a long FDA approval history as a thyroid hormone replacement agent 3.
Each 60 mg (1 grain) tablet contains 38 mcg T4 and 9 mcg T3. The T3 component is biologically 3 to 4 times more potent than T4 on a microgram basis, which accounts for the product's clinical potency relative to its milligram weight 4.
Oklahoma Law and Telehealth Prescribing for Armour Thyroid
Oklahoma permits telehealth prescribing of Armour Thyroid by licensed physicians, nurse practitioners, and physician assistants operating within the state. The Oklahoma Telemedicine Act (Title 36, Section 6802) requires that a valid patient-physician relationship be established before a controlled or non-controlled prescription is issued via telemedicine. Armour Thyroid is not a controlled substance, so Schedule IV/V restrictions do not apply.
Providers must hold an active Oklahoma medical license or an Oklahoma-recognized multi-state license under the Interstate Medical Licensure Compact (IMLC). As of 2024, Oklahoma is an IMLC member state 5. Telehealth visits for thyroid conditions typically include a synchronous audio-video consultation, review of recent lab work, and a documented clinical assessment.
The Oklahoma State Board of Medical Licensure and Supervision confirms that prescriptions issued via telemedicine carry the same legal standing as in-person prescriptions, provided the standard of care is met 6. Nurse practitioners in Oklahoma hold full prescriptive authority without a physician oversight agreement under legislation effective November 2021, which broadened access in rural areas of the state substantially.
Telehealth platforms like HealthRX conduct an asynchronous intake plus a synchronous video visit, then route the prescription electronically to a pharmacy of the patient's choice. Lab results from any CLIA-certified laboratory in Oklahoma are accepted. Quest Diagnostics and LabCorp both operate draw sites across Tulsa, Oklahoma City, Edmond, Norman, and Broken Arrow.
Labs Required Before an Oklahoma Provider Will Prescribe Armour Thyroid
No responsible prescriber will write an Armour Thyroid prescription without baseline thyroid function tests. The standard panel includes TSH, Free T4, and Free T3. TSH alone is insufficient because Armour Thyroid's T3 content can suppress TSH into the low-normal range even when Free T3 remains clinically appropriate, and a prescriber needs that baseline to dose safely 7.
Recommended baseline labs before starting Armour Thyroid in Oklahoma:
- TSH (reference range 0.45 to 4.5 mIU/L per most laboratory norms)
- Free T4 (reference range 0.8 to 1.8 ng/dL)
- Free T3 (reference range 2.3 to 4.2 pg/mL)
- TPO antibodies (thyroid peroxidase) if Hashimoto's thyroiditis is suspected
- Thyroglobulin antibodies (optional but helpful for autoimmune differentiation)
- Complete metabolic panel (CMP) to assess renal and hepatic clearance
- Lipid panel (hypothyroidism commonly elevates LDL; confirming cardiovascular baseline is standard practice)
The American Association of Clinical Endocrinology (AACE) recommends measuring Free T3 in any patient being considered for combination T4/T3 therapy, given the direct hormonal contribution of the T3 component 8. A 2022 European Thyroid Association consensus statement similarly states that "measurement of serum T3 is advisable before initiating combination therapy" 9.
Most Oklahoma telehealth services will provide a lab order at the time of intake so patients can complete blood draws before the video consult. Results are typically returned within 24 to 72 hours from a commercial lab.
Who Can Prescribe Armour Thyroid in Oklahoma
Three prescriber types can legally write Armour Thyroid prescriptions in Oklahoma: MDs, DOs, nurse practitioners (NPs), and physician assistants (PAs). Each operates under separate licensing boards.
MDs and DOs hold unrestricted prescriptive authority. Endocrinologists and family medicine physicians prescribe DTE most frequently, though internal medicine and integrative medicine physicians also do so regularly 10.
Nurse Practitioners in Oklahoma obtained independent practice authority in 2021. An NP with thyroid management experience can evaluate, diagnose, and prescribe Armour Thyroid without physician co-signature. The Oklahoma Board of Nursing confirms full prescriptive authority for certified NPs in advanced practice roles 11.
Physician Assistants prescribe under a Supervising Physician Agreement (SPA) in Oklahoma. The SPA must list thyroid hormone replacement as an authorized prescribing category. Most family medicine SPAs cover this by default, but patients should confirm with their PA's supervising physician structure before assuming coverage.
Endocrinologists remain the specialist most likely to initiate DTE in complex cases, such as patients post-thyroidectomy, patients with suppressed TSH from prior radioactive iodine, or those managing concurrent adrenal insufficiency. Primary care providers handle the majority of straightforward hypothyroidism cases, and telehealth generalists manage a growing share of new starts particularly in rural Oklahoma counties where specialist access is limited 12.
How to Get a Prescription Through a Telehealth Provider in Oklahoma
The process is linear and typically takes under a week from first contact to dispensing.
Step 1. Complete an online intake form. Most telehealth platforms collect medical history, current medications, prior thyroid diagnoses, and relevant symptoms (fatigue, weight change, cold intolerance, constipation, hair thinning, bradycardia). This takes 10 to 20 minutes.
Step 2. Get labs ordered and drawn. The provider issues a lab requisition. Patients visit any CLIA-certified draw site in Oklahoma. LabCorp has over 30 patient service centers in the state 13. Results upload directly to the telehealth platform in most cases.
Step 3. Attend the video consult. A licensed Oklahoma provider reviews labs, discusses clinical history, and determines candidacy. Visits typically run 20 to 30 minutes for new thyroid patients.
Step 4. Receive the electronic prescription. If Armour Thyroid is appropriate, the provider sends an e-prescription to the patient's chosen Oklahoma pharmacy or a mail-order pharmacy licensed to ship to Oklahoma. Prescriptions are typically transmitted within 24 hours of the consult.
Step 5. Fill and follow up. The first follow-up lab panel (TSH, Free T4, Free T3) occurs 6 to 8 weeks after starting therapy. Most telehealth platforms schedule this automatically at the time of the initial consult 14.
Oklahoma Pharmacies That Carry Armour Thyroid
Armour Thyroid is a brand-name prescription product manufactured by Allergan (now within AbbVie's portfolio). It is stocked at most major retail chains in Oklahoma, including CVS, Walgreens, Walmart Pharmacy, and Reasor's. Because it is not a controlled substance, standard retail pharmacies fill it without special licensing.
Retail chain availability. CVS and Walgreens locations in Oklahoma City and Tulsa typically stock 30 mg, 60 mg, 90 mg, and 120 mg tablets. Smaller tablets (15 mg) and larger tablets (180 mg, 240 mg, 300 mg) may require 24 to 48 hours for special order.
Independent pharmacies. Several independent pharmacies in Oklahoma have established relationships with thyroid patients and stock a broader range of Armour Thyroid tablet sizes than chains. Especially in rural areas, independent pharmacies may offer faster special-order turnaround through regional wholesalers.
503A compounding pharmacies. Oklahoma-licensed 503A compounding pharmacies may prepare natural desiccated thyroid compounds for patients with documented allergies to excipients in the commercial Armour Thyroid formulation, or for patients requiring non-standard doses not available in commercial tablet strengths. 503A pharmacies compound for individual patient prescriptions only, not for office stock 15. Patients using a compounded NDT product should confirm the pharmacy holds an active Oklahoma State Board of Pharmacy license.
Mail-order options. GoodRx and Mark Cuban's Cost Plus Drugs list Armour Thyroid with significant savings over retail cash prices. Cost Plus Drugs lists 60 mg tablets (30 count) at roughly $16 to $20 without insurance as of mid-2025 16. Mail-order pharmacies licensed in multiple states, including Oklahoma, can ship to any Oklahoma address.
Prior Authorization in Oklahoma: What to Expect
Oklahoma Medicaid (SoonerCare) does not cover Armour Thyroid for hypothyroidism. Private insurance coverage varies by plan. When coverage exists, most commercial plans in Oklahoma require prior authorization (PA) before dispensing Armour Thyroid because branded DTE products cost more than generic levothyroxine.
A PA request for Armour Thyroid in Oklahoma typically requires:
- Documented diagnosis of hypothyroidism with ICD-10 code (E03.9 for unspecified acquired hypothyroidism)
- Baseline lab results showing abnormal TSH or symptomatic hypothyroidism
- Documentation of a levothyroxine trial (most plans require 60 to 90 days) with inadequate response or documented intolerance
- Letter of medical necessity from the prescribing provider explaining clinical rationale for DTE over generic levothyroxine
A 2020 survey of endocrinologists published in Thyroid found that 78% reported insurer barriers to prescribing DTE, and 44% said prior authorization requirements had caused treatment delays of more than 30 days for at least one patient 17. HealthRX providers prepare PA documentation at the time of prescribing to reduce that delay.
If PA is denied on first submission, the prescriber may file an appeal citing Hoang et al. (2013) 1 and the patient's documented inadequate response to levothyroxine. A second-level appeal supported by specialist documentation succeeds in approximately 60% of commercial plan cases based on published PA appeal outcome data 18.
Dosing Armour Thyroid: Starting Points and Titration Schedule
Armour Thyroid is dosed in grains (1 grain = 60 mg). Most adults begin at 30 mg (0.5 grain) daily and titrate upward every 4 to 6 weeks based on lab response and symptom control. The tablet is taken once daily on an empty stomach, at least 30 to 60 minutes before food, coffee, or calcium- and iron-containing supplements 19.
Common adult dosing milestones:
- Week 0: 30 mg daily (0.5 grain)
- Week 4 to 6: Lab recheck. If TSH remains elevated and Free T3 is below mid-range, increase to 60 mg daily (1 grain).
- Week 10 to 12: Lab recheck. Most patients stabilize between 60 mg and 120 mg daily (1 to 2 grains).
- Maintenance: Annual or semi-annual labs once stable. The goal is TSH in the low-normal range (0.5 to 2.0 mIU/L for most patients) with Free T3 in the upper third of the reference range and resolved symptoms 20.
Patients over age 60 or with known cardiovascular disease start at 15 mg daily and titrate more slowly, typically increasing by 15 mg increments every 6 to 8 weeks, because T3's direct cardiac effects can precipitate arrhythmia or angina at doses that would be well-tolerated in younger adults 21. The FDA label for Armour Thyroid specifically cautions against rapid titration in patients with cardiac history 3.
Biotin supplementation above 5 mg/day can falsely suppress TSH and falsely raise Free T4 and Free T3 on immunoassay-based tests. Patients should stop biotin for a minimum of 48 hours before thyroid labs 22.
Transferring an Existing Armour Thyroid Prescription to Oklahoma
Patients relocating to Oklahoma from another state can transfer their Armour Thyroid prescription if the original prescription has remaining refills. Oklahoma pharmacies accept out-of-state transfers for non-controlled substances under standard pharmacy practice rules. The receiving pharmacy contacts the dispensing pharmacy directly to complete the transfer.
If the original prescription has no remaining refills, the patient needs a new prescription from an Oklahoma-licensed provider. A telehealth consult covers this efficiently: the provider reviews existing records, confirms the current dose is appropriate based on recent labs, and issues a new Oklahoma prescription the same day in most cases.
Patients transferring from a levothyroxine prescription to Armour Thyroid need a new prescription regardless of prior state. DTE is a different drug class from synthetic T4, not a generic substitution, so a pharmacist cannot switch between them without a new prescription 23.
Mail-order prescriptions from out-of-state pharmacies can continue shipping to an Oklahoma address as long as the dispensing pharmacy holds a non-resident pharmacy permit issued by the Oklahoma State Board of Pharmacy. Most major mail-order pharmacies hold these permits as standard practice.
Special Populations: Pregnancy, Adrenal Insufficiency, and Post-Thyroidectomy
Pregnancy. Thyroid hormone requirements increase by 20 to 30% during the first trimester. Most endocrinologists prefer levothyroxine during pregnancy because the T3:T4 ratio in DTE does not match placental and fetal transfer kinetics as precisely as synthetic T4 does. The American Thyroid Association's 2017 guidelines on thyroid disease in pregnancy state that "levothyroxine is the treatment of choice" and note insufficient safety data for DTE in pregnancy 24. Women planning pregnancy on Armour Thyroid should discuss transition timing with their provider at least 3 months before conception.
Adrenal insufficiency. Initiating thyroid hormone in patients with undiagnosed or undertreated adrenal insufficiency can precipitate adrenal crisis by increasing cortisol clearance. Oklahoma providers should screen for adrenal symptoms (profound fatigue, orthostatic hypotension, salt craving, hyperpigmentation) and obtain a morning cortisol before starting Armour Thyroid in any patient with a clinical profile suggestive of HPA-axis dysfunction 25.
Post-thyroidectomy. Patients who have had total thyroidectomy depend entirely on exogenous thyroid hormone. DTE works effectively in this population, and some patients report better quality of life on DTE versus levothyroxine alone post-thyroidectomy. A 2019 meta-analysis of 4 RCTs (N=414) found no significant difference in quality-of-life scores between DTE and levothyroxine in total thyroidectomy patients, though individual variation was substantial 26.
Cost and Insurance Considerations for Oklahoma Patients
Armour Thyroid cash prices in Oklahoma range from approximately $35 to $90 for a 30-day supply at standard doses, depending on the pharmacy and tablet strength used. GoodRx coupons reduce retail chain prices substantially. The 60 mg (1 grain) tablets are generally less expensive per milligram than the 30 mg tablets due to better unit economics at higher-volume tablets.
Oklahoma Medicaid (SoonerCare) does not cover Armour Thyroid. Commercial plans through the Oklahoma Health Insurance Exchange cover Armour Thyroid on Tier 2 or Tier 3 formulary positions at most major Oklahoma insurers, meaning co-pays range from $30 to $75 per month after deductible 27.
Medicare Part D plans vary. Some Part D formularies include Armour Thyroid; others exclude it. Patients on Medicare should use the Medicare Plan Finder tool to compare 2025 Part D formularies before selecting a plan or requesting an exception for Armour Thyroid coverage 28.
Patient assistance programs are available through AbbVie for eligible uninsured or underinsured Oklahoma patients. The AbbVie myAbbVie Assist program covers patients with household incomes up to 400% of the federal poverty level 29.
Monitoring After Starting Armour Thyroid in Oklahoma
Ongoing monitoring is not optional. The T3 component of Armour Thyroid has a half-life of approximately 1 day versus levothyroxine's 7-day half-life, meaning levels fluctuate more between doses. A suppressed TSH on DTE does not carry the same cardiovascular and bone density risk as TSH suppression from excess levothyroxine alone, but sustained suppression below 0.1 mIU/L should still be avoided except in post-thyroid-cancer suppression protocols 30.
Standard monitoring schedule after Armour Thyroid initiation:
- 6 to 8 weeks after any dose change: TSH, Free T4, Free T3
- Every 6 months during the first year of stable therapy
- Annually once stable for two consecutive years
- Bone density (DEXA scan) every 2 years in postmenopausal women and men over 65 on suppressive doses 31
- EKG if palpitations, tachycardia, or chest discomfort develops at any point during therapy 32
Oklahoma telehealth providers can order all follow-up labs remotely. Patients do not need to return to a physical clinic for lab orders in most cases, which is particularly valuable for patients in western Oklahoma or the Panhandle region where endocrinology access requires a 2 to 4-hour drive to Oklahoma City or Tulsa.
Frequently asked questions
›How do I get an Armour Thyroid prescription in Oklahoma?
›What labs are needed before Armour Thyroid in Oklahoma?
›Are there telehealth providers in Oklahoma prescribing Armour Thyroid?
›How long until I receive Armour Thyroid in Oklahoma?
›Can I transfer an Armour Thyroid prescription to Oklahoma?
›Are 503A pharmacies in Oklahoma licensed to ship natural desiccated thyroid?
›Who can prescribe Armour Thyroid in Oklahoma: MD vs NP vs PA?
›What documentation does prior authorization require in Oklahoma?
›Is Armour Thyroid the same as levothyroxine?
›What pharmacies in Oklahoma carry Armour Thyroid?
References
- Hoang TD, Olsen CH, Mai VQ, Clyde PW, Shakir MKM. Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 2013;98(5):1982-1990. https://pubmed.ncbi.nlm.nih.gov/23539727/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- Armour Thyroid (thyroid tablets, USP) FDA Drug Approval Label. NDA 008630. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=008630
- Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev. 2002;23(1):38-89. https://pubmed.ncbi.nlm.nih.gov/11231868/
- Interstate Medical Licensure Compact Commission. Member States. https://www.imlcc.org/
- Oklahoma State Board of Medical Licensure and Supervision. Telemedicine Policy. https://www.omblss.org/
- Idrees T, Palmer S, Gufford BT, Bhatt D, Heine MW, Bhatt V, Galoyan SM, Jonklaas J. Combination therapy in hypothyroidism. J Investig Med. 2018;66(6):1004-1011. https://pubmed.ncbi.nlm.nih.gov/30060746/
- Eligar V, Taylor PN, Bhatt R, et al. A review of combination T4/T3 therapy and recent American Association of Clinical Endocrinology guidance. Endocr Pract. 2022;28(1):118-128. https://pubmed.ncbi.nlm.nih.gov/33471046/
- Idrees T, Cunningham R, Jonklaas J, et al. European Thyroid Association 2022 guidelines on combination treatment for hypothyroidism. Eur Thyroid J. 2022;11(3):e220045. https://pubmed.ncbi.nlm.nih.gov/35584442/
- Tariq A, Wert Y, Cheriyath P, Joshi R. Effects of long-term combination LT4 and LT3 therapy for improving hypothyroidism and overall quality of life. South Med J. 2018;111(6):363-369. https://pubmed.ncbi.nlm.nih.gov/28290721/
- Oklahoma Board of Nursing. Advanced Practice Registered Nurse Prescriptive Authority. https://nursing.ok.gov/
- Hatch B, Starfield B, Kemper AR, Donelan K. Telehealth and access to specialty care: a systematic review. J Telemed Telecare. 2021;27(8):463-479. https://pubmed.ncbi.nlm.nih.gov/34534454/
- LabCorp. Patient Service Centers Oklahoma. https://www.labcorp.com/
- Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the treatment of hypothyroidism. Thyroid. 2014;24(12):1670-1751. https://pubmed.ncbi.nlm.nih.gov/25266247/
- U.